EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.4.1.90 | Uterine Cervical Neoplasms |
26987623 |
B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells. |
causal interaction
diagnostic usage
ongoing research
unassigned |
2
3
3
0 |
| 2.4.1.90 | Infections |
12433481 |
Beta-(1 --> 4)-galactosyltransferase activity in native and engineered insect cells measured with time-resolved europium fluorescence. |
causal interaction
unassigned |
3
0 |
| 2.4.1.90 | Glioma |
20816157 |
Beta1,4-galactosyltransferase V A growth regulator in glioma. |
causal interaction
unassigned |
3
0 |
| 2.4.1.90 | Glioma |
16461357 |
Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
3
4
0 |
| 2.4.1.90 | Glioma |
20417617 |
beta1,4-Galactosyltransferase V regulates self-renewal of glioma-initiating cell. |
therapeutic application
unassigned |
1
0 |
| 2.4.1.90 | Arthritis, Rheumatoid |
20490888 |
beta1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
4
3 |
| 2.4.1.90 | Carcinogenesis |
17470362 |
beta4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
4
3
0 |
| 2.4.1.90 | Herpes Zoster |
2824254 |
Binding of caput epididymal mouse sperm to the zona pellucida. |
unassigned |
0 |
| 2.4.1.90 | Vesicular Stomatitis |
18269347 |
Calsenilin and CALP interact with the cytoplasmic tail of UDP-Gal:GA2/GM2/GD2 beta-1,3-galactosyltransferase. |
unassigned |
0 |
| 2.4.1.90 | Carcinoma, Embryonal |
2503706 |
Cell surface and Golgi pools of beta-1,4-galactosyltransferase are differentially regulated during embryonal carcinoma cell differentiation. |
causal interaction
ongoing research
unassigned |
1
3
0 |
